Wayne
Pisano President and Chief
Executive
Officer
Wayne F.
Pisano
Joins
VaxInnate
as
CEO. He
is the
former
President
and
Chief
Executive
Officer
of sanofi
pasteur.
Christine
C. Mayer, VP
Business
Development
Christine
Mayer
joined
VaxInnate
as Vice
President,
Business
Development
in
August
2012.Christine
is a
multi-disciplined
executive
David Taylor MD Chief Medical Officer
Dr. Taylor, Chief Medical Officer, joined VaxInnate in March 2007 from Salix Pharmaceuticals, where he served as Chief Medical Officer and VP, Medical Affairs.
Lynda Tussey, Ph.D. VP
Research
&
Development
Dr. Tussey joined VaxInnate in 2004 from Purdue Pharma where, as Program Leader of Immunotherapeutics,
she led
the
overall
development
of
cancer
vaccine
program
VaxInnate is a privately-held biotechnology company developing novel, proprietary vaccines for both pandemic and seasonal influenza.
The company's breakthrough vaccines are based on its Toll-like receptor (TLR) technology platform, which dramatically improves vaccine immunogenicity and efficacy.
VaxInnate was founded by Ruslan Medzhitov and Richard Flavell, both of Yale University and Howard Hughes Medical Institute and leaders in the field of innate immunity.
The company started in 2002 with a research team in New Haven, CT. In 2004, the company expanded and established a development team and corporate headquarters in Cranbury, NJ.
Katalin
Abraham, 
Christine
C. Mayer, 
David Taylor MD 
Lynda Tussey, Ph.D. 
+1 609 860 2260